Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

A demonstration of ''less can be more'' in risk graphics.

Zikmund-Fisher BJ, Fagerlin A, Ubel PA.

Med Decis Making. 2010 Nov-Dec;30(6):661-71. doi: 10.1177/0272989X10364244. Epub 2010 Apr 7.

2.

Improving understanding of adjuvant therapy options by using simpler risk graphics.

Zikmund-Fisher BJ, Fagerlin A, Ubel PA.

Cancer. 2008 Dec 15;113(12):3382-90. doi: 10.1002/cncr.23959.

3.
4.

The benefits of discussing adjuvant therapies one at a time instead of all at once.

Zikmund-Fisher BJ, Angott AM, Ubel PA.

Breast Cancer Res Treat. 2011 Aug;129(1):79-87. doi: 10.1007/s10549-010-1193-4. Epub 2010 Oct 14.

5.

Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs.

Zikmund-Fisher BJ, Ubel PA, Smith DM, Derry HA, McClure JB, Stark A, Pitsch RK, Fagerlin A.

Patient Educ Couns. 2008 Nov;73(2):209-14. doi: 10.1016/j.pec.2008.05.010.

6.

Animated graphics for comparing two risks: a cautionary tale.

Zikmund-Fisher BJ, Witteman HO, Fuhrel-Forbis A, Exe NL, Kahn VC, Dickson M.

J Med Internet Res. 2012 Jul 25;14(4):e106. doi: 10.2196/jmir.2030.

7.

Mortality versus survival graphs: improving temporal consistency in perceptions of treatment effectiveness.

Zikmund-Fisher BJ, Fagerlin A, Ubel PA.

Patient Educ Couns. 2007 Apr;66(1):100-7. Epub 2006 Nov 29.

PMID:
17137743
8.

The influence of graphic display format on the interpretations of quantitative risk information among adults with lower education and literacy: a randomized experimental study.

McCaffery KJ, Dixon A, Hayen A, Jansen J, Smith S, Simpson JM.

Med Decis Making. 2012 Jul-Aug;32(4):532-44. doi: 10.1177/0272989X11424926. Epub 2011 Nov 10.

PMID:
22074912
9.
10.

Cool but counterproductive: interactive, Web-based risk communications can backfire.

Zikmund-Fisher BJ, Dickson M, Witteman HO.

J Med Internet Res. 2011 Aug 25;13(3):e60. doi: 10.2196/jmir.1665.

11.

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.

J Natl Cancer Inst. 2005 Jan 19;97(2):116-26.

PMID:
15657341
12.

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H; Austrian Breast and Colorectal Cancer Study Group.

J Natl Cancer Inst. 2007 Dec 19;99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6;100(3):226.

PMID:
18073378
14.

Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer.

Vickers AJ, Elkin EB, Peele PB, Dickler M, Siminoff LA.

Med Decis Making. 2009 Jul-Aug;29(4):461-7. doi: 10.1177/0272989X08329344. Epub 2009 Mar 6.

15.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
16.

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

PMID:
11512506
17.
18.

Lack of survival gain for elderly women with breast cancer.

Bastiaannet E, Portielje JE, van de Velde CJ, de Craen AJ, van der Velde S, Kuppen PJ, van der Geest LG, Janssen-Heijnen ML, Dekkers OM, Westendorp RG, Liefers GJ.

Oncologist. 2011;16(4):415-23. doi: 10.1634/theoncologist.2010-0234. Epub 2011 Mar 15.

19.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
20.

Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation.

Haines TP, Sinnamon P, Wetzig NG, Lehman M, Walpole E, Pratt T, Smith A.

Breast Cancer Res Treat. 2010 Nov;124(1):163-75. doi: 10.1007/s10549-010-1126-2. Epub 2010 Aug 24.

PMID:
20734132

Supplemental Content

Support Center